Impact of parity on the incidence of ovarian cancer subtypes: a population-based case

Impact of parity on the incidence of ovarian cancer subtypes: a population-based case–control study

Published:2021-05-17 Issue:7 Volume:60 Page:850-855
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Toufakis Vasileios¹²,Katuwal Sushmita³,Pukkala Eero³⁴,Tapanainen Juha S.¹⁵

Affiliation:

1. Department of Obstetrics and Gynecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland

2. Department of Obstetrics and Gynecology, Seinäjoki Central Hospital, Seinäjoki, Finland

3. Faculty of Social Sciences, Tampere University, Tampere, Finland

4. Finnish Cancer Registry, Institute for Statistical and Epidemiological Cancer Research, Helsinki, Finland

5. Department of Obstetrics and Gynecology, University of Oulu and Oulu University Hospital, Medical Research Center, PEDEGO Research Unit, Oulu, Finland

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2021.1919754

Reference30 articles.

1. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium

2. Different Risk Factor Profiles for Mucinous and Nonmucinous Ovarian Cancer: Results from the Danish MALOVA Study

3. Histological subtypes of ovarian cancer associated with parity and breastfeeding in the prospective Million Women Study

4. Incidence of ovarian cancer of grand multiparous women—A population-based study in Finland

5. Incidence of cancer among grand multiparous women in Finland with special focus on non-gynaecological cancers: A population-based cohort study

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between parity and female mortality: the mediative role of depressive symptoms;Human Reproduction;2024-08-30

2. Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements;International Journal of Molecular Sciences;2024-02-03

3. Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle?;Cancer Treatment Reviews;2023-12

4. Molecular Management of High-Grade Serous Ovarian Carcinoma;International Journal of Molecular Sciences;2022-11-09

5. BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation;Frontiers in Oncology;2022-08-17